Literature DB >> 16616480

Silencing of autoreactive B cells by anergy: a fresh perspective.

Stephen B Gauld1, Kevin T Merrell, John C Cambier.   

Abstract

B-cell antigen receptor (BCR) signals are crucial for initiation of humoral immune responses and must be actively modulated and/or terminated in preparation for receipt of subsequent cues for progression. BCR signaling is also actively inhibited in autoreactive cells in which unresponsiveness is maintained by anergy. This serves to prevent cell activation and autoimmunity. Importantly, the feedback mechanisms that modulate and/or terminate signaling during normal antigen-induced B-cell activation appear to also be involved in maintaining B-cell anergy. In fact, it is suggested that anergy reflects nothing more than the normal inability of cells to respond to antigen following preceding stimulation of normal inhibitory feedback mechanisms. Thus, the time-honored two-signal hypothesis is almost certainly correct, with second signals being required to release the cell from inhibitory BCR-specific and trans-active feedback regulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16616480     DOI: 10.1016/j.coi.2006.03.015

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  25 in total

1.  Cellular competition independent of BAFF/B lymphocyte stimulator results in low frequency of an autoreactive clonotype in mature polyclonal B cell compartments.

Authors:  Neda Nikbakht; Thi-Sau Migone; Chris P Ward; Tim Manser
Journal:  J Immunol       Date:  2011-06-01       Impact factor: 5.422

Review 2.  IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease.

Authors:  Jarod Zepp; Ling Wu; Xiaoxia Li
Journal:  Trends Immunol       Date:  2011-04-12       Impact factor: 16.687

Review 3.  Understanding B-cell tolerance through the use of immunoglobulin transgenic models.

Authors:  Kirthi Raman Kumar; Chandra Mohan
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

4.  Ikaros in B cell development and function.

Authors:  Maclean Sellars; Philippe Kastner; Susan Chan
Journal:  World J Biol Chem       Date:  2011-06-26

Review 5.  Calcium Signaling: From Normal B Cell Development to Tolerance Breakdown and Autoimmunity.

Authors:  Patrice Hemon; Yves Renaudineau; Marjolaine Debant; Nelig Le Goux; Sreya Mukherjee; Wesley Brooks; Olivier Mignen
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

6.  Modulation of B-cell tolerance by murine gammaherpesvirus 68 infection: requirement for Orf73 viral gene expression and follicular helper T cells.

Authors:  Stephen B Gauld; Jessica L De Santis; Joseph M Kulinski; Jennifer A McGraw; Steven M Leonardo; Elizabeth A Ruder; Weston Maier; Vera L Tarakanova
Journal:  Immunology       Date:  2013-06       Impact factor: 7.397

7.  Activation of thyroid antigen-reactive B cells in recent onset autoimmune thyroid disease patients.

Authors:  Mia J Smith; Marynette Rihanek; Brianne M Coleman; Peter A Gottlieb; Virginia D Sarapura; John C Cambier
Journal:  J Autoimmun       Date:  2017-12-09       Impact factor: 7.094

Review 8.  B cells in type 1 diabetes mellitus and diabetic kidney disease.

Authors:  Mia J Smith; Kimber M Simmons; John C Cambier
Journal:  Nat Rev Nephrol       Date:  2017-10-17       Impact factor: 28.314

9.  Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs.

Authors:  Ping Xie; Laura L Stunz; Karen D Larison; Baoli Yang; Gail A Bishop
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

10.  Augmented B lymphocyte response to antigen in the absence of antigen-induced B lymphocyte signaling in an IgG-transgenic mouse line.

Authors:  Rong-Yong Man; Taishi Onodera; Emi Komatsu; Takeshi Tsubata
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.